Online citations, reference lists, and bibliographies.
← Back to Search

Beneficial Effect Of High Dose Statins On The Vascular Wall In Patients With Repaired Aortic Coarctation?

P. Luijendijk, B. Bouma, J. Vriend, M. Groenink, H. Vliegen, E. de Groot, P. Pieper, A. V. van Dijk, G. Sieswerda, T. Konings, E. Stroes, A. Zwinderman, B. Mulder
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
BACKGROUND Carotid intima-media thickness (CIMT) is a marker for atherosclerosis. Adult post-coarctectomy patients (CoA) demonstrate an increased cardiovascular risk and increased CIMT compared to controls. This study evaluates the effect of high dose statins on the change in CIMT and cardiovascular risk. METHODS We designed a multicenter, prospective, randomized, open label trial with blinded endpoint (PROBE design) to evaluate the effect of three year treatment with atorvastatin 80 mg on CIMT and cardiovascular risk. Primary endpoint was CIMT measured by B mode ultrasonography. Secondary endpoints were mortality and morbidity due to cardiovascular disease and serum lipids. RESULTS 155 patients (36.3 ± 11.8 years, 96 (62%) male) were randomized (atorvastatin=80, no treatment=75). There was no significant effect of atorvastatin on the change in CIMT (treatment effect -0.005, 95% CI, -0.039-0.029; P=0.76). A significant effect on serum cholesterol and LDL levels was found (- 0.71, 95% CI, - 1.16 to - 0.26; P = 0.002 vs - 0.66, 95% CI - 1.06 to - 0.26; P = 0.001). There was no difference in secondary outcome measures. Baseline CIMT was higher in hypertensive compared to normotensive CoA. (0.69 ± 0.16 mm vs 0.61 ± 0.98 mm; P=0.002). Hypertension (ß=0.043, P=0.031) was the strongest determinant CIMT. CONCLUSION Three year treatment with atorvastatin does not lead to a reduction of CIMT and secondary outcome measures, despite a decrease in total cholesterol and LDL levels. Hypertensive CoA demonstrate the highest CIMT and the largest CIMT progression. Blood pressure control should be the main focus in CoA to decrease cardiovascular risk.
This paper references
10.1016/0002-8703(47)90002-1
Coarctation of the aorta; a review of 104 autopsied cases of the adult type, 2 years of age or older.
G. H. Reifenstein (1947)
10.1111/j.1651-2227.1964.tb05158.x
Statistical Methods
G. W. Snedecor (1964)
10.2307/2987141
Statistical methods
G. W. Snedecor (1980)
10.1161/01.CIR.65.6.1060
Different reactivity and structure of the prestenotic and poststenotic aorta in human coarctation. Implications for baroreceptor function.
J. Sehested (1982)
10.1161/01.CIR.80.4.840
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction.
M. Cohen (1989)
10.1097/00005344-199117002-00008
Does hypertension potentiate atherosclerosis via vascular hypertrophy?
V. Dzau (1991)
10.1016/S0140-6736(01)05378-8
Repair of coarctation of the aorta and hypertension: does age matter
S. Daniels (2001)
10.1016/S0002-9149(01)02293-7
Long-term follow-up of patients after coarctation of the aorta repair.
Olga H Toro-Salazar (2002)
10.1016/S1047-2797(01)00280-0
A regression model for longitudinal change in the presence of measurement error.
N. Yanez (2002)
10.1161/01.STR.0000088643.07108.19
Risk Factors for Progression of Atherosclerosis Measured at Multiple Sites in the Arterial Tree: The Rotterdam Study
I. M. van der Meer (2003)
10.1159/000074799
Statins and Stroke Prevention
P. Amarenco (2003)
[National registry and DNA-bank of patients with congenital heart disease: the CONCOR-project].
J. Vriend (2004)
10.1161/01.STR.0000136720.21095.f3
Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness: The Carotid Atherosclerosis Progression Study
A. Mackinnon (2004)
10.1007/s10654-005-3854-x
CONCOR, An Initiative towards a National Registry and DNA-bank of Patients with Congenital Heart Disease in the Netherlands: Rationale, Design, and Frst Results
E. V. D. Velde (2005)
10.1093/EURHEARTJ/EHI037
Predicting the risk of early atherosclerotic disease development in children after repair of aortic coarctation.
A. A. Meyer (2005)
Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
A. Shukla (2005)
Treatment of hypertension: guidelines from JNC 7 (the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 1).
Mary Linda Stotter Cuddy (2005)
10.1016/J.IJCARD.2004.03.056
Late complications in patients after repair of aortic coarctation: implications for management.
J. Vriend (2005)
10.1136/HRT.2004.045245
Carotid intima–media thickness in post-coarctectomy patients with exercise induced hypertension
J. Vriend (2005)
10.1186/1468-6708-6-3
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
M. Espeland (2005)
10.1016/J.ATHEROSCLEROSIS.2005.01.030
Evidence of vascular dysfunction in young patients with successfully repaired coarctation of aorta.
S. Brili (2005)
10.1016/J.AHJ.2005.02.013
Increased carotid and femoral intima-media thickness in patients after repair of aortic coarctation: influence of early repair.
J. Vriend (2006)
10.1161/STROKEAHA.108.528174
Impact of Prehypertension on Common Carotid Artery Intima-Media Thickness and Left Ventricular Mass
E. Manios (2009)
10.1016/j.atherosclerosis.2008.12.009
Surrogate markers in clinical trials--challenges and opportunities.
R. Duivenvoorden (2009)
10.1093/eurheartj/ehq185
Imaging of atherosclerosis: carotid intima-media thickness.
D. O'leary (2010)
10.1016/j.amjcard.2011.03.063
Usefulness of exercise-induced hypertension as predictor of chronic hypertension in adults after operative therapy for aortic isthmic coarctation in childhood.
P. Luijendijk (2011)
10.1038/hr.2011.22
Hypertension and coarctation of the aorta: an inevitable consequence of developmental pathophysiology
D. Kenny (2011)
10.1007/s12471-011-0198-x
Percutaneous treatment of native aortic coarctation in adults
P. Luijendijk (2011)
10.1136/heartjnl-2011-300287
Effects of atorvastatin on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young subjects with successfully repaired coarctation of aorta
S. Brili (2011)
10.1016/j.cct.2011.11.011
Rationale and design of a trial on the effect of high dose statins on cardiovascular risk in adults after successful coarctation repair.
P. Luijendijk (2012)
10.1586/erc.12.158
Surgical versus percutaneous treatment of aortic coarctation: new standards in an era of transcatheter repair
P. Luijendijk (2012)
10.1016/j.jacc.2011.12.061
Lessons from the past and promises for the future for carotid intima-media thickness.
M. Bots (2012)
10.1161/CIRCULATIONAHA.111.088294
Coarctation of the Aorta and Coronary Artery Disease: Fact or Fiction?
I. Roifman (2012)
10.1016/S0140-6736(12)60441-3
Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data
M. Lorenz (2012)
10.1161/CIRCULATIONAHA.112.116293
Aortic coarctation and coronary artery disease: the XY factor.
C. Bondy (2012)
10.1016/j.ijcard.2013.03.068
The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials.
M. Banach (2013)
10.1016/j.ijcard.2012.02.014
Increased risk for ascending aortic dilatation in patients with complex compared to simple aortic coarctation.
P. Luijendijk (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar